MISSION® pLKO.1-puro B2M shRNA Control Plasmid DNA

Positive control targeting B2M

MISSION Control Vectors
MDL number:
Pricing and availability is not currently available.

product line


shipped in

dry ice

storage temp.


Looking for similar products? Visit Product Comparison Guide

General description

This control is intended for use as a positive control for knockdown of human gene targets when used with clones of the MISSION TRC human shRNA collections. The DNA format of this control construct permits direct transfection in knockdown experiments or use in the viral packaging process (for lentiviral-based knockdown experiments).

The MISSION Beta-2-Microglobulin (B2M) shRNA Control Vector is a lentiviral-based plasmid vector that contains a short hairpin sequence targeting the human Beta-2-Microglobulin transcript (Gene Symbol: B2M). Beta-2-microglobulin is a MHC Class I molecule present on most cell types. It is commonly used as an endogenous control due to this universal expression. The vector backbone is the same as the MISSION TRC shRNA collections (pLKO.1). The B2M clone (TRCN0000057254) was chosen from the available complete target set (NM_004048) and has produced consistent knockdown of 80% compared to normal gene expression in the human epithelial lung carcinoma cell line A549 via quantitative RT PCR analysis.

Ampicillin and puromycin antibiotic resistance genes provide selection in bacterial or mammalian cells respectively. In addition, self-inactivating replication incompetent viral particles can be produced in packaging cells (HEK293T) by co-transfection with compatible packaging plasmids (Product No. SHP001). The MISSION Beta-2-Microglobulin (B2M) shRNA Control Vector is provided as 10 μg of plasmid DNA in Tris-EDTA (TE) buffer at a concentration of 500 ng/μl.


To see more application data, protocols, vector maps visit

Legal Information

Use of this product is subject to one or more license agreements. For details, please see
MISSION is a registered trademark of Sigma-Aldrich Co. LLC

WGK Germany


Ruth S Cruz Cosme et al.
Journal of virology, 83(7), 2839-2850 (2009-01-16)
Human cytomegalovirus (HCMV), a member of the beta subgroup of the family Herpesviridae, causes serious health problems worldwide. HCMV gene expression in host cells is a well-defined sequential process: immediate-early (IE) gene expression, early-gene expression, DNA replication, and late-gene expression....

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.